Advanced Pathophysiology Unit 5 CV Page 1 of 24. Learning Objectives:

Size: px
Start display at page:

Download "Advanced Pathophysiology Unit 5 CV Page 1 of 24. Learning Objectives:"

Transcription

1 Advanced Pathophysiology Unit 5 CV Page 1 of 24 Learning Objectives: 1) What is the definition of HF? How can we get it? Is it just the failing heart? 2) AHA/ACC stages of HF compared to older NYHA classes of functional HF 3) Recognize that LV failure can be SYSTOLIC (low output) or DIASTOLIC (high output) and know the etiologies of these types of LV failure 4) Understand the compensatory mechanisms that are initiated due to LV Systolic HF and how this results in progressive worsening of cardiac function over time 5) Recognize the contribution of longstanding HTN to HF 6) Recognize the rational approach to management of HF with current understanding of pathophysiologic mechanisms 7) Understand the etiology and compensatory changes that occur in RV HF.

2 Advanced Pathophysiology Unit 5 CV Page 2 of 24 METs AS AN ESTIMATE OF FUNCTIONAL CAPACITY/PROGNOSIS: Part of preop evaluation and prognostic determination Don t mix this up with MetSyn (Metabolic Syndrome a cardiometabolic disorder) Exercise Capacity and METs: We are measuring exercise capacity reported in metabolic equivalents of task (METs) These are units based on the metabolic resting oxygen uptake while sitting. o 1 MET = oxygen consumed at rest = 3.5 ml of oxygen/kg/min. Examples of METs: o I am always surprised to see that a METs of 6 is bedmaking! It always seems like hard work to me! o Carrying a suitcase is a METs of 7. METs testing results and prognosis: o Exercise capacity of 5 METs or less expect poor prognosis in patients <65 yo o Exercise capacity of 10 METs expect prognosis with medical therapy same as CABG o Exercise capacity of 13 METs is a good prognosis even if the exercise testing reveals abnormal EKG or BP responses Predictive value of METs: Expected values for age have been established and deviations are predictive of coronary survival rates Gulati M, et al. The prognostic vlaue of a nomogram for exercise capacity in women. N Eng J Med 4 Aug 2005; 353(5):

3 Advanced Pathophysiology Unit 5 CV Page 3 of 24 WHAT IS THE DEFINITION OF HEART FAILURE (HF)?? inability of the heart to supply enough blood carrying oxygen & nutrients for the needs of the body's tissues. also called congestive heart failure (CHF) when there is fluid accumulation that is clinically significant however, this is really an OLDER term, and the current abbreviation is really just HF You do not have to have congestion in order to have HF your goal is to diagnose HF long before congestive symptoms (by the time the patient is symptomatic, we have missed the diagnosis by years and years) Many ways to get HF may NOT be the fault of the HEART!!! body needs more O2 (hypermetabolic state) heart is actually fine insufficient RBC to carry O2 (anemias) heart is actually fine failure of myocardium (pump) to provide sufficient SV per heartbeat (insufficient CO) due to poor preload return (e.g. dehydration) heart is actually fine Thus, metabolic needs, hematologic and volume factors play a role, not just cardiac issues.

4 Advanced Pathophysiology Unit 5 CV Page 4 of 24 HF ETIOLOGY: (see also pictures next pages) Cardiac: clinicians usually refer to Left Ventricular dysfunction when they talk about HR disease states that reduce ventricular contractility OR reduce compliance ( stiff ventricle ) Examples: o valvular heart disease (increases myocardial work load) o coronary artery disease (reduces oxygen supply to the heart) o intrinsic myocardial diseases (cardiomyopathies hypertension, alcoholism, etc.) Howeve, it is now recognized that right ventricular dysfunction is also found in MANY HF patients Non-cardiac causes of HF: systemic diseases (anemia with reduced viscosity) high CO states such as in thyrotoxicosis, pregnancy, AV fistula LOW-output heart failure (from Left Ventricular Systolic Dysfunction): the heart is pumping LESS blood/minute, due to systolic HF, reduced CO LOW output HF is usually what is referred to when we use the term HF clinically Due to underperfusion of the kidney, the RAS is activated and eventually volume overload occurs HIGH-output heart failure from Left Ventricular Diastolic Dysfunction: the LV is functioning well and the heart may be pumping LOTS of blood BUT the tissues are still not receiving sufficient supply. Causes: o when the heart receives too much venous return (decreased TPR) o greatly increased blood volume overloading the heart and causing increased atrial pressures with fluid backup (like in thyrotoxicosis, pregnancy). Diastolic dysfunction is a form of high output failure o can lead to pulmonary venous congestion, even with normal systolic ventricular function. o Found in disease of ventricular filling Anything making the ventricle STIFF (reduced LV compliance) Includes ventricular scarring, hypertrophy, ischemic cardiomyopathy, hypertensive cardiomyopathy, amyloidosis, sarcoidosis Hypertrophic Normal Dilated Different cardiac remodeling changes (cardiomyopathy) the LV may be hypertrophic (increased muscle mass) or dilated; either change interferes with normal filling (diastole) and contraction (systole).

5 Advanced Pathophysiology Unit 5 CV Page 5 of 24 Typically we are referring to cardiac problems (not systemic) when we talk about HF: Usually there is dysfuncton of the left ventricle This can be systolic or diastolic Usually secondary to longstanding Hypertension, RAS activation Comorbidities include cardiac ischemia Complications include ischemic cardiomyopathy & dysrhythmias (arrhythmias)

6 Advanced Pathophysiology Unit 5 CV Page 6 of 24 TALKING ABOUT LEFT VENTRICULAR HF:

7 Advanced Pathophysiology Unit 5 CV Page 7 of 24 Left ventricular disease causing HF may be Systolic or Diastolic: Systolic is LV pump failure associated with volume overload and eventual edema, pulmonary congestion (the typical picture of HF as envisioned by most clinicians) o Also referred to as low output Diastolic is LV stiffness poor compliance, poor filling actually has normal ejection fraction and there isn t any volume overload o Also referred to as high output Patients can have either type, or a combination of both Typically, when people talk about HF due to LV dysfunction, they are thinking about LV pump failure and systolid dysfunction However, it is becoming increasingly obvious that diastolic dysfunction of the LV is important in the etiology of HF as well THIS CHART ILLUSTRATES FINDINGS IN LEFT VENTRICULAR HF: May be SYSTOLIC OR DIASTOLIC OR A COMBINATION OF BOTH

8 Advanced Pathophysiology Unit 5 CV Page 8 of 24 AHA/ACC HF STAGES COMPARED TO OLDER NYHA FUNCTIONAL CLASSES : NO LONGER WAIT FOR SYMPTOMS OR FUNCTIONAL DISABIILTY TO MAKE THE DIAGNOSIS The diagnosis is made on risk factors and evidence of structural heart disease (e.g. on CXR, EKG, echocardiogram, other diagnostic studies) Symptomatic disease is the result of failure to diagnose early and treat early Early intervention is now the practice guideline Recommendations are for guideline-directed medical therapy (GDMT) AHA/ACC 2013 CPG for Heart Failure Executive Summary: Full CPG: Determination of Ejection Fraction: Is it preserved? Is it reduced? Current terminology: o HF with preserved EF is termed: HFpEF (EF 50% or more)( diastolic HF) o HF with reduced EF is termed: HFrEF (EF 40% or less)( systolic HF)

9 Advanced Pathophysiology Unit 5 CV Page 9 of 24 Stages of HF:

10 Advanced Pathophysiology Unit 5 CV Page 10 of 24 FIRST LET S TALK ABOUT LEFT VENTRICULAR SYSTOLIC HF: low output HF LV Systolic HF: Defects in the SYSTOLIC contractile state cause a reduced ejection fraction This decreased circulation of blood will result in reduced venous return to the heart. OVERALL there is reduced CO This creates compensatory changes in the RAS that result in fluid overload. (see more next pages) FROM: McMurray JJV. Systolic Heart Failure. NEJM 21 January 2010;362(3): (with permission)

11 Advanced Pathophysiology Unit 5 CV Page 11 of 24 LV Systolic HF: Pump Failure (LV failure) Backward Effects Forward Effects Cardiac Poor ejection fraction LV reduced compliance Reduced cardiac output Increased LVEDP Increased LA pressure Increased Pulmonary artery pressure Pulmonary Symptoms cough, dyspnea, DOE PND, orthopnea, Pulmonary Signs cyanosis auscultatory crackles & rales Reduced GFR & poor renal perfusion Activate RAS fluid retention LVH accelerated atherosclerosis worsened pump function (preload & afterload) Reduce CO & BP Adaptive changes Increased HR increased MVO2 cardiac ischemia Peripheral edema (pitting from extravasated protein due to high pressures) see below for discussion

12 Advanced Pathophysiology Unit 5 CV Page 12 of 24 Symptoms & signs: cyanosis fatigue dyspnea (sense of oxygen debt & breathlessness) due to both poor tissue circulation as well as poor oxygenation at the lung from pulmonary congestion. What worsens HF decompensation: o Anything placing a greater workload on the heart (exercise, stress, illness, surgery) o Anything lessening pump effectiveness (atrial fibrillation and loss of atrial kick) will worsen the HF. Cardiac changes: due to compensatory mechanisms designed to increase the venous return (preload, or LVEDP). This increases the SV according to the Frank-Starling curve o increased filling leads to increased ventricular stretch o increased LVEDP in turn causes increased contractility. However, this improved contractility only lasts up to a point o once the LVEDP becomes too high, cardiac function declines o now you are left with a large, STIFF ventricle that is POORLY COMPLIANT. Even diastolic filling becomes difficult! Can t relax enough to fill. Plus, disease causes increased energy requirements even for diastolic relaxation (remember relaxation is an active process). Pulmonary edema: HP > COP in pulmonary capillaries Back pressure into the lungs develops (since the left atrium and left ventricle are not accepting and ejecting blood properly), with pulmonary vascular congestion. This means that there is an increase in the pulmonary capillary pressures (PCP), exceeding the COP net fluid filtration from vascular space to pulmonary interstitium. Once fluid enters the interstitium, this is pulmonary edema, a medical emergency. Hypercapnia & hypoxia will be seen when this stage is reached. The kidney talks to the heart, the heart talks to the kidney to worsen left systolic HF: Increasing blood volume (renin-angiotensin-aldosterone): o Due to poor renal perfusion in HF, the RAS system is activated, increasing blood volume. o This is initially helpful but leads to overshoot and worsened pump action with development of pulmonary edema. Thus, systolic heart failure is usually associated with INCREASED BLOOD VOLUMES

13 Advanced Pathophysiology Unit 5 CV Page 13 of 24 Compensatory ( adaptive ) physiologic measures of the failing left heart: Compensatory hypertrophy (LVH) & dilatation: o allows a greater filling and increased LVEDP o with greater force of contractility (increased SV & EF). o But, eventually, dilatation & hypertrophy become disease in itself, with a stiff noncompliant ventricle that exceeds the benefits of the Frank-Starling curve and we now have diastolic heart failure (see below) Exacerbation of myocardial ischemia: o the LVH may exacerbate coronary ischemia o since coronary artery blood flow may not be sufficient to supply the thickened myocardium with the necessary coronary muscle blood supply o Plus, the stiff ventricle has a high MVO2 requirement and worsens angina Remodeling as a long term complication of infarct: o when infarct & loss of muscle tissue is the cause of the failing heart o the term VENTRICULAR REMODELING indicates that compensatory ventricular dilatation & hypertrophy has taken place in response to the infarct o Improved cardiac output (temporarily) but at the expense of a stiff (noncompliant) LV that develops diastolic heart failure (see below) Reduced Renal Perfusion Activates the RAS to raise the CO: o angiotensin-ii, ADH, Aldosterone o fluid and salt loading, blood volume expansion preload o increased sympathetic nervous system activity afterload & increased inotropy And remember the additional changes in the body include compensatory increase in the TPR: Sympathetic stimulation: o sympathetic stimulation causes peripheral vasoconstriction to enhance preload. o But, this also raises the MVO2 and worsens the condition. o Eventual long term result is worsened heart failure RAS activation: o Increasing blood volume (renin-angiotensin-aldosterone): Due to poor renal perfusion in HF, the RAS system is activated, increasing blood volume. This is initially helpful but leads to overshoot and worsened pump action with development of pulmonary edema. o Thus, systolic heart failure is usually associated with INCREASED BLOOD VOLUMES

14 Advanced Pathophysiology Unit 5 CV Page 14 of 24 A continuum of worsened pathology: Anatomical changes in the heart over time based on comorbid factors: You may hear of eccentric vs. concentric changes in the anatomy of the heart The actual remodeling of the left ventricle may differ, based on the factors leading to HF

15 Advanced Pathophysiology Unit 5 CV Page 15 of 24 Eventually what happens? Loss of Ejection Fraction and cardiac decompensation : Is it preserved? Is it reduced? Current terminology: o HF with preserved EF is termed: HFpEF (EF 50% or more)( diastolic HF) o HF with reduced EF is termed: HFrEF (EF 40% or less)( systolic HF) Classification of acutely decompensated HF LOSS of ejection fraction:

16 Advanced Pathophysiology Unit 5 CV Page 16 of 24 Clinical result: Ventricular Remodeling compensatory hypertrophy (LVH) & dilatation striving to maintain ejection fraction after infarct: o when infarct & loss of muscle tissue is the cause of the failing heart o the term VENTRICULAR REMODELING indicates that compensatory ventricular dilatation & hypertrophy has taken place in response to the infarct o Improved cardiac output (temporarily) o allows a greater filling and increased LVEDP with greater force of contractility (increased SV & EF) to improve the CO for the body o But, eventually, dilatation & hypertrophy become disease in itself, with a stiff noncompliant ventricle that exceeds the benefits of the Frank-Starling curve. Exacerbation of myocardial ischemia: LVH may exacerbate coronary ischemia since coronary artery blood flow may NOT be sufficient to supply the thickened myocardium with the necessary coronary muscle blood supply Plus, the stiff ventricle will have a higher MVO2 requirement and also worsens angina Reduced Renal Perfusion Activates the RAS to raise the CO: o angiotensin-ii, ADH, Aldosterone are released o fluid and salt loading occurs with blood volume expansion preload o increased sympathetic nervous system activity increased afterload & increased inotropy Final result: o inotropic stress & chronotropic stress, with increased MVO2 requirement o poor perfusion and renal activation of the RAS with increased volume/salt loading o worsened angina (chest pain), cardiac decompensation (pulmonary & peripheral edema) o reduced ejection fraction (EF < 50%) Pharmacologic correlate rationale for drug therapy: ACE-inhibitors (ACEI) and ARBs (angiotensin receptor blockers) are now utilized in the management of HF; the long-term use of these agents can actually REVERSE remodeling & compensatory LVH. diuretics are also used to relieve congestion from fluid overload caused by activation of the RAS Beta-blockers are used to blockade the Beta-1 receptor on the heart and reduce inotropy & chronotropy, both reducing the MVO2 required for cardiac function. Aldosterone antagonists prevent the Na/H20 retention from this hormone. Severe decompensated HF is treated with IV Natrecor, which is actually exactly the same atrial natriuretic peptide (ANP) hormone the atria make in fluid overload.

17 Advanced Pathophysiology Unit 5 CV Page 17 of 24 SUMMARY of LV SYSTOLIC HF: In HF, the compensatory mechanisms are designed to increase the CO to meet the demands of the tissues Mechanisms: o Sympathetic discharge increased heart rate, increased inotropy, RAS activation o RAS activation (from hypoperfusion) volume loading, vasoconstriction, cardiac remodeling Overall effects of compensatory mechanisms: o Increased EF (ejection fraction) initially due to the compensation o Increased afterload via peripheral vasoconstriction (sympathetic, RAS) o Increased vascular compartment volume from systemic activation and reserve volume (stored in legs and spleen) restored to blood vessels o This also improves preload return to the heart o Increased preload stretches heart and results in better force of contraction (inotropy) o At the same time, local tissue factors may promote vasodilatation to meet the tissue s need for oxygen better perfusion of the tissues also results in increased preload return to the heart o Increased heart rate (HR) How these compensatory changes help the body INITIALLY: o INITIALLY improved preload, improved vascular volume, positive inotropy, positive chronotropy all raise the CO at first How this all EVENTUALLY hurts the heart and makes everything WORSE: o Overall, longstanding compensatory changes of increased inotropy, increased chronotropy, increased preload (volume loading), increased LV muscle mass (LVH) create myocardial ischemia, myocardial cell damage (cardiomyopathy) and worsening LV function. o Increased chronotropy (HR) diastolic phase is shortened (more than the systolic phase) this is when the coronary vessels receive their blood; the coronary circulation is reduced & less blood is delivered to the myocardium o Increased inotropy & chronotropy more cardiac muscle demand for oxygen, at just the time when the coronary vessels are delivering less blood!! o LVH makes the muscle thicker and it is harder to deliver blood to this thick muscle mass; LVH also makes the ventricle stiff and it can t fill during diastole o Acute decompensation will occur with symptomatic HF (edema, pulmonary congestion) ejection fraction is NO LONGER PRESERVED o All of these compensatory changes from the sympathetic NS & the RAS raise the MVO2 just at a time when the blood delivery is being reduced! So, in heart failure the tissues need more oxygen it is tempting to increase the CO to meet the demands of the tissues but you need to worry about the MvO2!! Read the above paragraph a few times so you ve got it this is the current view of HF pathophysiology. This is why the current treatment is to BLOCK the RAS (ACEI & ARB drugs), BLOCK the sympathetic NS (beta-blockers); and NOT to use cardiotonics like digoxin. Diuretics are still used to treat edema/congestion on a PRN basis for patient relief if congestion symptoms occur in later stages of HF, but these drugs do not alter the actual pathology of HF.

18 Advanced Pathophysiology Unit 5 CV Page 18 of 24 NOW LET S TALK ABOUT ANOTHER LV PATHOLOGY: WHAT IS DIASTOLIC LEFT VENTRICULAR FAILURE? high output HF This is still left ventricular pathology: Results from any condition that causes REDUCED COMPLIANCE of the LV Thus, the LV is stiffer Think: o post-mi scarring o left ventricular hypertrophy (thickened myocardium) o other cardiomyopathies and other conditions (e.g., amyloidosis, sarcoidosis) Typically: o The myocytes are not efficient in extracting and using oxygen o There is often evidence of myocyte disease or dysfunction ( sick myocytes ) Differences in pathophysiology: Does NOT activate the renin-angiotensin system Blood volumes are NOT elevated EF (ejection fraction) is maintained (>50%) Difference in clinical presentation: May be very difficult to recognize that there is diastolic heart failure in early stages May only be recognized towards the end of the natural history of the development of the condition

19 Advanced Pathophysiology Unit 5 CV Page 19 of 24 Graphic of the differences between LV systolic & LV diastolic dysfunction:

20 Advanced Pathophysiology Unit 5 CV Page 20 of 24 LASTLY WHAT IS COMBINED DIASTOLIC & SYSTOLIC LEFT VENTRICULAR HF? When both systolic AND diastolic failure is present, the clinical presentation may be very complex and not as physiologically simple More common than previously thought

21 Advanced Pathophysiology Unit 5 CV Page 21 of 24 MOVING ON LEAVING THE LEFT VENTRICLE WHAT ABOUT RIGHT VENTRICULAR SYSTOLIC HEART FAILURE? There can be a failure of the myocardium in the right ventricle as well Findings are different clinically than in left ventricular systolic failure Note that the systolic phase we are referring to here is for the RIGHT ventricle Usually due to pulmonary disease and called cor pulmnale (see more below) May also be due to longstanding LV systolic failure (see more next page) Right Ventricular Failure Backward Effects Forward Effects Decreased Ejection Fraction Decreased output to left ventricle Increased right ventricle preload Decreased left ventricular cardiac output Increased right atrial pressure Systemic Congestion hepatosplenomegaly anorexia peripheral edema jugular vein distension Findings reduced GFR oliguria fatigue decreased mentation narrow pulse pressure faint pulses increased HR See discussion below

22 Advanced Pathophysiology Unit 5 CV Page 22 of 24 Primary RV failure: acute, usually RV infarct if the RV fails, as much as 50% of pulmonary blood is shifted into the systemic circulation (5% of total body blood volume) results in a lack of venous return to the heart. Treatment of acute RV failure: Sounds strange it is rapid continuous fluid infusion to maintain return of blood to the left heart and presersve systemic CO Etiology: RV infarct. RV failure due to pulmonary conditions Cor pulmonale: enlarged RV due to any cause OTHER than LV failure. This might be due to primary lung disease & chronic pulmonary artery afterload pressures. A clue that this is the case: o hypercapnia & hypoxemia are severe early in the disease (pulmonary component) o unlike in LV failure, ABG abnormalities only occur during the last stages with terminal pulmonary edema Etiologies: usually lung pathologies such as primary/idiopathic pulmonary hypertension, pulmonary emboli, & COPD. RV failure due to LV failure (HF): LV failure increases PCP in the pulmonary vascular compartment (see LV heart failure, above). If this congestion becomes very high, pulmonary artery hypertension (pulmonary hypertension) occurs, giving an afterload increase to the RV & overloading the RV. Cardiac etiologies: o NOT called cor pulmonale o is a high output cardiac failure, with usually large volumes of blood o such as in tricuspid regurgitation, Atrial Septal Defect (ASD) where blood to travels from the left right heart with RV overload).

23 Advanced Pathophysiology Unit 5 CV Page 23 of 24 EKG FINDINGS OF CARDIAC HYPERTROPHY: ATRIAL HYPERTROPHY right and left: Right atrial hypertrophy (enlargement) (RAE): Same as above, except there is a tall initial component Left Atrial hypertrophy (enlargement)(lae): Large P wave Diphasic P wave with wide terminal component (look in lead II) Usually indicates pulmonary disease (e.g. COPD) VENTRICULAR HYPERTROPHY right and left: Right ventricular hypertrophy (RVH): R > S in V1 (tall R in V1 & V2), R gets smaller from V1 V6 S wave persists in V5 & V6 RAD with widened QRS May also RAE Confirm diagnosis with echocardiogram o Color Flow Doppler gives more information blood flow, valves, wall motion, ejection fraction, etc. (but is more expensive) This tracing has RVH & RAE

24 Advanced Pathophysiology Unit 5 CV Page 24 of 24 Left ventricular hypertrophy (LVH): S wave V1 + R wave V5 > 35 mm COUNT THE BOXES FOR MM ELEVATION o This is called voltage criteria for LVH o There are other ways (probably more accurate) to diagnose LVH on EKG LAD with widened QRS Inverted T wave with gradual downward slant and then rapid upstroke o LVH with strain o When the strain pattern is seen, the diagnosis of LVH is more accurate o Usually the result of longstanding HTN or valvular obstruction o Note that LVH with strain identifies hypertensive patients at risk of developing HF and also dying of HF (even with aggressive BP management) (the LIFE study) How to confirm LVH diagnosis: o If EKG signs of LVH, always order an echocardiogram to confirm o The Color Flow Doppler Echo will give more information about the blood flow, ejection fraction, and wall motion but it is more expensive Sometimes, a limited Echo is done to simply look for o Ventricular hypertrophy or Septal hypertrophy o These are the gold standard of LVH diagnosis o If confirmed, a Color Flow Doppler can be ordered How to decide which ECHO to order?? o The Athlete: The normal athlete may have EKG signs of LVH But, the physical exam is normal and no evidence of cardiovascular disease so this would be a good candidate for the limited Echo o The hypertensive patient: Any signs of LVH here are probably due to cardiac changes from HTN Go ahead with the Color Flow Doppler

Copyright 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Normal Cardiac Anatomy

Copyright 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Normal Cardiac Anatomy Mosby,, an affiliate of Elsevier Normal Cardiac Anatomy Impaired cardiac pumping Results in vasoconstriction & fluid retention Characterized by ventricular dysfunction, reduced exercise tolerance, diminished

More information

Heart Failure. Subjective SOB (shortness of breath) Peripheral edema. Orthopnea (2-3 pillows) PND (paroxysmal nocturnal dyspnea)

Heart Failure. Subjective SOB (shortness of breath) Peripheral edema. Orthopnea (2-3 pillows) PND (paroxysmal nocturnal dyspnea) Pharmacology I. Definitions A. Heart Failure (HF) Heart Failure Ezra Levy, Pharm.D. HF Results when one or both ventricles are unable to pump sufficient blood to meet the body s needs There are 2 types

More information

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output Cardiac Anatomy Heart Failure Professor Qing ZHANG Department of Cardiology, West China Hospital www.blaufuss.org Cardiac Cycle/Hemodynamics Functions of the Heart Essential functions of the heart to cover

More information

Congestive Heart Failure Patient Profile. Patient Identity - Mr. Douglas - 72 year old man - No drugs, smokes, moderate social alcohol consumption

Congestive Heart Failure Patient Profile. Patient Identity - Mr. Douglas - 72 year old man - No drugs, smokes, moderate social alcohol consumption Congestive Heart Failure Patient Profile Patient Identity - Mr. Douglas - 72 year old man - No drugs, smokes, moderate social alcohol consumption Chief Complaint - SOB - When asked: Increasing difficulty

More information

Topic Page: congestive heart failure

Topic Page: congestive heart failure Topic Page: congestive heart failure Definition: congestive heart f ailure from Merriam-Webster's Collegiate(R) Dictionary (1930) : heart failure in which the heart is unable to maintain an adequate circulation

More information

Definition of Congestive Heart Failure

Definition of Congestive Heart Failure Heart Failure Definition of Congestive Heart Failure A clinical syndrome of signs & symptoms resulting from the heart s inability to supply adequate tissue perfusion. CHF Epidemiology Affects 4.7 million

More information

Images have been removed from the PowerPoint slides in this handout due to copyright restrictions.

Images have been removed from the PowerPoint slides in this handout due to copyright restrictions. Heart Failure Heart Failure Introduction and History AHA 2015 Statistics About 6 million Americans 870,000 new cases each year 1 in 9 deaths related to HF Almost 1 million hospitalizations each year (cost

More information

HFpEF. April 26, 2018

HFpEF. April 26, 2018 HFpEF April 26, 2018 (J Am Coll Cardiol 2017;70:2476 86) HFpEF 50% or more (40-71%) of patients with CHF have preserved LV systolic function. HFpEF is an increasingly frequent hospital discharge. Outcomes

More information

A Guide to the Etiology, Pathophysiology, Diagnosis, and Treatment of Heart Failure. Part I: Etiology and Pathophysiology of Heart Failure

A Guide to the Etiology, Pathophysiology, Diagnosis, and Treatment of Heart Failure. Part I: Etiology and Pathophysiology of Heart Failure A Guide to the Etiology, Pathophysiology, Diagnosis, and Treatment of Heart Failure Dr Badri Paudel GMC Part I: Etiology and Pathophysiology of Heart Failure Heart Failure (HF) Definition A complex clinical

More information

Improving Transition of Care in Congestive Heart Failure. Mark J. Gloth, DO, MBA. Vice President, Chief Medical Officer HCR ManorCare

Improving Transition of Care in Congestive Heart Failure. Mark J. Gloth, DO, MBA. Vice President, Chief Medical Officer HCR ManorCare Improving Transition of Care in Congestive Heart Failure Mark J. Gloth, DO, MBA. Vice President, Chief Medical Officer HCR ManorCare Heart Failure Fastest growing clinical cardiac disease in the United

More information

Heart Failure (HF) Treatment

Heart Failure (HF) Treatment Heart Failure (HF) Treatment Heart Failure (HF) Complex, progressive disorder. The heart is unable to pump sufficient blood to meet the needs of the body. Its cardinal symptoms are dyspnea, fatigue, and

More information

Pathophysiology: Heart Failure

Pathophysiology: Heart Failure Pathophysiology: Heart Failure Mat Maurer, MD Irving Assistant Professor of Medicine Outline Definitions and Classifications Epidemiology Muscle and Chamber Function Pathophysiology Heart Failure: Definitions

More information

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV. Valvular Heart Disease Etiology General Principles Cellular and molecular mechanism of valve damage Structural pathology Functional pathology - stenosis/regurgitation Loading conditions - pressure/volume

More information

Pre-discussion questions

Pre-discussion questions Amanda Bartlett, PA-C Dustin Bartlett, PA-C Andrea Applegate, PA-C Leslie Yearta Brown, NP CHF Round Table Discussion Objectives ANDREA- Discuss the definition and different categories of CHF DUSTIN- Define

More information

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV.

Ejection across stenotic aortic valve requires a systolic pressure gradient between the LV and aorta. This places a pressure load on the LV. Valvular Heart Disease General Principles Etiology Cellular and molecular mechanism of valve damage Structural pathology Functional pathology - stenosis/regurgitation Loading conditions - pressure/volume

More information

Outline. Pathophysiology: Heart Failure. Heart Failure. Heart Failure: Definitions. Etiologies. Etiologies

Outline. Pathophysiology: Heart Failure. Heart Failure. Heart Failure: Definitions. Etiologies. Etiologies Outline Pathophysiology: Mat Maurer, MD Irving Assistant Professor of Medicine Definitions and Classifications Epidemiology Muscle and Chamber Function Pathophysiology : Definitions An inability of the

More information

Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept

Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept (MBBS)(SBMD) Introduction Epidemiology Pathophysiology diastolic/systolic Risk factors Signs and symptoms Classification of HF

More information

HEART FAILURE. Study day November 2018 Sarah Briggs

HEART FAILURE. Study day November 2018 Sarah Briggs HEART FAILURE Study day November 2018 Sarah Briggs Overview and Introduction This course is an introduction and overview of heart failure. Normal heart function and basic pathophysiology of heart failure

More information

Cor pulmonale. Dr hamid reza javadi

Cor pulmonale. Dr hamid reza javadi 1 Cor pulmonale Dr hamid reza javadi 2 Definition Cor pulmonale ;pulmonary heart disease; is defined as dilation and hypertrophy of the right ventricle (RV) in response to diseases of the pulmonary vasculature

More information

The Causes of Heart Failure

The Causes of Heart Failure The Causes of Heart Failure Andy Birchall HFSN Right heart failure LVSD - HFREF Valve regurgitation or stenosis Dropsy CCF congestive cardiac failure Cor pulmonale Pulmonary hypertension HFPEF LVF Definitions

More information

Congestive Heart Failure

Congestive Heart Failure Sheri Saluga Anatomy and Physiology II March 4, 2010 Congestive Heart Failure Scenario George is in congestive heart failure. Because of his condition, his ankles and feet appear to be swollen and he has

More information

Physiology #14. Heart Failure & Circulatory Shock. Mohammad Ja far Tuesday 5/4/2016. Turquoise Team. Page 0 of 13

Physiology #14. Heart Failure & Circulatory Shock. Mohammad Ja far Tuesday 5/4/2016. Turquoise Team. Page 0 of 13 45 Physiology #14 Heart Failure & Circulatory Shock Mohammad Ja far Tuesday 5/4/2016 Turquoise Team Page 0 of 13 Heart Failure: It s a condition in which the heart can t perform its function properly;

More information

Index of subjects. effect on ventricular tachycardia 30 treatment with 101, 116 boosterpump 80 Brockenbrough phenomenon 55, 125

Index of subjects. effect on ventricular tachycardia 30 treatment with 101, 116 boosterpump 80 Brockenbrough phenomenon 55, 125 145 Index of subjects A accessory pathways 3 amiodarone 4, 5, 6, 23, 30, 97, 102 angina pectoris 4, 24, 1l0, 137, 139, 140 angulation, of cavity 73, 74 aorta aortic flow velocity 2 aortic insufficiency

More information

Circulation. Blood Pressure and Antihypertensive Medications. Venous Return. Arterial flow. Regulation of Cardiac Output.

Circulation. Blood Pressure and Antihypertensive Medications. Venous Return. Arterial flow. Regulation of Cardiac Output. Circulation Blood Pressure and Antihypertensive Medications Two systems Pulmonary (low pressure) Systemic (high pressure) Aorta 120 mmhg Large arteries 110 mmhg Arterioles 40 mmhg Arteriolar capillaries

More information

Pathophysiology: Heart Failure. Objectives

Pathophysiology: Heart Failure. Objectives Pathophysiology: Heart Failure Mat Maurer, MD Irving Assistant Professor of Clinical Medicine Objectives At the conclusion of this seminar, learner will be able to: 1. Define heart failure as a clinical

More information

Means failure of heart to pump enough blood to satisfy the need of the body.

Means failure of heart to pump enough blood to satisfy the need of the body. Means failure of heart to pump enough blood to satisfy the need of the body. Due to an impaired ability of the heart to adequately to fill or eject blood. HEART FAILURE Heart failure (HF) means decreased

More information

M2 TEACHING UNDERSTANDING PHARMACOLOGY

M2 TEACHING UNDERSTANDING PHARMACOLOGY M2 TEACHING UNDERSTANDING PHARMACOLOGY USING CVS SYSTEM AS AN EXAMPLE NIGEL FONG 2 JAN 2014 TODAY S OBJECTIVE Pharmacology often seems like an endless list of mechanisms and side effects to memorize. To

More information

Cardiovascular Physiology. Heart Physiology. Introduction. The heart. Electrophysiology of the heart

Cardiovascular Physiology. Heart Physiology. Introduction. The heart. Electrophysiology of the heart Cardiovascular Physiology Heart Physiology Introduction The cardiovascular system consists of the heart and two vascular systems, the systemic and pulmonary circulations. The heart pumps blood through

More information

Diastolic Heart Failure. Edwin Tulloch-Reid MBBS FACC Consultant Cardiologist Heart Institute of the Caribbean December 2012

Diastolic Heart Failure. Edwin Tulloch-Reid MBBS FACC Consultant Cardiologist Heart Institute of the Caribbean December 2012 Diastolic Heart Failure Edwin Tulloch-Reid MBBS FACC Consultant Cardiologist Heart Institute of the Caribbean December 2012 Disclosures Have spoken for Merck, Sharpe and Dohme Sat on a physician advisory

More information

During exercise the heart rate is 190 bpm and the stroke volume is 115 ml/beat. What is the cardiac output?

During exercise the heart rate is 190 bpm and the stroke volume is 115 ml/beat. What is the cardiac output? The Cardiovascular System Part III: Heart Outline of class lecture After studying part I of this chapter you should be able to: 1. Be able to calculate cardiac output (CO) be able to define heart rate

More information

HEART FAILURE PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

HEART FAILURE PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D HEART FAILURE PHARMACOLOGY University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D 1 LEARNING OBJECTIVES Understand the effects of heart failure in the body

More information

ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure Patients t with acute heart failure frequently develop chronic heart failure Patients with chronic heart failure frequently decompensate acutely ESC Guidelines for the Diagnosis and A clinical response

More information

BIOL 219 Spring Chapters 14&15 Cardiovascular System

BIOL 219 Spring Chapters 14&15 Cardiovascular System 1 BIOL 219 Spring 2013 Chapters 14&15 Cardiovascular System Outline: Components of the CV system Heart anatomy Layers of the heart wall Pericardium Heart chambers, valves, blood vessels, septum Atrioventricular

More information

Failing Heart. Cardiac Resynchronization: novel therapy for the

Failing Heart. Cardiac Resynchronization: novel therapy for the Advanced Studies in Medicine Cardiac Resynchronization: novel therapy for the Failing Heart Module 1: Understanding the Scope of Heart Failure, A Review of the Concepts of Anatomy & Physiology THE JOHNS

More information

BUSINESS. Articles? Grades Midterm Review session

BUSINESS. Articles? Grades Midterm Review session BUSINESS Articles? Grades Midterm Review session REVIEW Cardiac cells Myogenic cells Properties of contractile cells CONDUCTION SYSTEM OF THE HEART Conduction pathway SA node (pacemaker) atrial depolarization

More information

Imaging in Heart Failure: A Multimodality Approach. Thomas Ryan, MD

Imaging in Heart Failure: A Multimodality Approach. Thomas Ryan, MD Imaging in Heart Failure: A Multimodality Approach Thomas Ryan, MD Heart Failure HFrEF HFpEF EF50% Lifetime risk 20% Prevalence 6M Americans Societal costs - $30B 50% 5-year survival 1 Systolic

More information

10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor

10/8/2018. Lecture 9. Cardiovascular Health. Lecture Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor Lecture 9 Cardiovascular Health 1 Lecture 9 1. Heart 2. Cardiovascular Health 3. Stroke 4. Contributing Factor 1 The Heart Muscular Pump The Heart Receives blood low pressure then increases the pressure

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

The right heart: the Cinderella of heart failure

The right heart: the Cinderella of heart failure The right heart: the Cinderella of heart failure Piotr Ponikowski, MD, PhD, FESC Medical University, Centre for Heart Disease Clinical Military Hospital Wroclaw, Poland none Disclosure Look into the Heart

More information

McHenry Western Lake County EMS System Paramedic, EMT-B and PHRN Optional Continuing Education 2018 #12 Understanding Preload and Afterload

McHenry Western Lake County EMS System Paramedic, EMT-B and PHRN Optional Continuing Education 2018 #12 Understanding Preload and Afterload McHenry Western Lake County EMS System Paramedic, EMT-B and PHRN Optional Continuing Education 2018 #12 Understanding Preload and Afterload Cardiac output (CO) represents the volume of blood that is delivered

More information

THE CARDIOVASCULAR SYSTEM

THE CARDIOVASCULAR SYSTEM THE CARDIOVASCULAR SYSTEM AND RESPONSES TO EXERCISE Mr. S. Kelly PSK 4U North Grenville DHS THE HEART: A REVIEW Cardiac muscle = myocardium Heart divided into two sides, 4 chambers (L & R) RS: pulmonary

More information

Diagnosis is it really Heart Failure?

Diagnosis is it really Heart Failure? ESC Congress Munich - 25-29 August 2012 Heart Failure with Preserved Ejection Fraction From Bench to Bedside Diagnosis is it really Heart Failure? Prof. Burkert Pieske Department of Cardiology Med.University

More information

Age-related changes in cardiovascular system. Dr. Rehab Gwada

Age-related changes in cardiovascular system. Dr. Rehab Gwada Age-related changes in cardiovascular system Dr. Rehab Gwada Objectives explain the main structural and functional changes in cardiovascular system associated with normal aging Introduction aging results

More information

Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood:

Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood: Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood: Cardiac Output (CO) CO=SVxHR (stroke volume x heart rate) Cardiac output: The amount of blood

More information

Cardiac Output MCQ. Professor of Cardiovascular Physiology. Cairo University 2007

Cardiac Output MCQ. Professor of Cardiovascular Physiology. Cairo University 2007 Cardiac Output MCQ Abdel Moniem Ibrahim Ahmed, MD Professor of Cardiovascular Physiology Cairo University 2007 90- Guided by Ohm's law when : a- Cardiac output = 5.6 L/min. b- Systolic and diastolic BP

More information

Diagnosis & Management of Heart Failure. Abena A. Osei-Wusu, M.D. Medical Fiesta

Diagnosis & Management of Heart Failure. Abena A. Osei-Wusu, M.D. Medical Fiesta Diagnosis & Management of Heart Failure Abena A. Osei-Wusu, M.D. Medical Fiesta Learning Objectives: 1) Become familiar with pathogenesis of congestive heart failure. 2) Discuss clinical manifestations

More information

Protocol Identifier Subject Identifier Visit Description. [Y] Yes [N] No. [Y] Yes [N] N. If Yes, admission date and time: Day Month Year

Protocol Identifier Subject Identifier Visit Description. [Y] Yes [N] No. [Y] Yes [N] N. If Yes, admission date and time: Day Month Year PAST MEDICAL HISTORY Has the subject had a prior episode of heart failure? o Does the subject have a prior history of exposure to cardiotoxins, such as anthracyclines? URGENT HEART FAILURE VISIT Did heart

More information

-12. -Ensherah Mokheemer - ABDULLAH ZREQAT. -Faisal Mohammad. 1 P a g e

-12. -Ensherah Mokheemer - ABDULLAH ZREQAT. -Faisal Mohammad. 1 P a g e -12 -Ensherah Mokheemer - ABDULLAH ZREQAT -Faisal Mohammad 1 P a g e In the previous lecture we talked about: - cardiac index: we use the cardiac index to compare the cardiac output between different individuals,

More information

Dysrhythmias. Dysrythmias & Anti-Dysrhythmics. EKG Parameters. Dysrhythmias. Components of an ECG Wave. Dysrhythmias

Dysrhythmias. Dysrythmias & Anti-Dysrhythmics. EKG Parameters. Dysrhythmias. Components of an ECG Wave. Dysrhythmias Dysrhythmias Dysrythmias & Anti-Dysrhythmics Rhythm bad in the heart: Whitewater rafting Electrical impulses coordinate heart Reduction in Cardiac Output PEA Asystole Components of an ECG Wave EKG Parameters

More information

HEART FAILURE. Study day November 2017 Sarah Briggs and Janet Laing

HEART FAILURE. Study day November 2017 Sarah Briggs and Janet Laing HEART FAILURE Study day November 2017 Sarah Briggs and Janet Laing Overview and Introduction This course is an introduction and overview of heart failure. Normal heart function and basic pathophysiology

More information

Presenter: Steven Brust, HCS-D, HCS-H Product Manager, Home Health Coding Center

Presenter: Steven Brust, HCS-D, HCS-H Product Manager, Home Health Coding Center Presenter: Steven Brust, HCS-D, HCS-H Product Manager, Home Health Coding Center Pinpoint & properly assign the appropriate heart failure codes Left- vs. Right-sided Left ventricular failure (LVF) may

More information

Structure and organization of blood vessels

Structure and organization of blood vessels The cardiovascular system Structure of the heart The cardiac cycle Structure and organization of blood vessels What is the cardiovascular system? The heart is a double pump heart arteries arterioles veins

More information

Heart Failure. Dr. William Vosik. January, 2012

Heart Failure. Dr. William Vosik. January, 2012 Heart Failure Dr. William Vosik January, 2012 Questions for clinicians to ask Is this heart failure? What is the underlying cause? What are the associated disease processes? Which evidence-based treatment

More information

Review of Cardiac Mechanics & Pharmacology 10/23/2016. Brent Dunworth, CRNA, MSN, MBA 1. Learning Objectives

Review of Cardiac Mechanics & Pharmacology 10/23/2016. Brent Dunworth, CRNA, MSN, MBA 1. Learning Objectives Brent Dunworth, CRNA, MSN, MBA Associate Director of Advanced Practice Division Chief, Nurse Anesthesia Vanderbilt University Medical Center Nashville, Tennessee Learning Objectives Review the principles

More information

HEART FAILURE. Heart Failure in the US. Heart Failure (HF) 3/2/2014

HEART FAILURE. Heart Failure in the US. Heart Failure (HF) 3/2/2014 HEART FAILURE Martina Frost, PA-C Desert Cardiology of Tucson Northwest Medical Center March 2014 Heart Failure in the US Prevalence - ~5 million 650,000 new cases annually 300,000 deaths annually Leading

More information

The Cardiovascular System

The Cardiovascular System The Cardiovascular System The Cardiovascular System A closed system of the heart and blood vessels The heart pumps blood Blood vessels allow blood to circulate to all parts of the body The function of

More information

Cardiac Output (C.O.) Regulation of Cardiac Output

Cardiac Output (C.O.) Regulation of Cardiac Output Cardiac Output (C.O.) Is the volume of the blood pumped by each ventricle per minute (5 Litre) Stroke volume: Is the volume of the blood pumped by each ventricle per beat. Stroke volume = End diastolic

More information

Pathophysiology: Heart Failure. Objectives

Pathophysiology: Heart Failure. Objectives Pathophysiology: Heart Failure Mat Maurer, MD Associate Professor of Clinical Medicine Objectives At the conclusion of this seminar, learners will be able to: 1. Define heart failure as a clinical syndrome

More information

Estimated 5.7 million Americans with HF. 915, 000 new HF cases annually, HF incidence approaches

Estimated 5.7 million Americans with HF. 915, 000 new HF cases annually, HF incidence approaches Heart Failure: Management of a Chronic Disease Jenny Bauerly RN, CHFN, APRN-BC Heart Failure (HF) Definition A complex clinical syndrome that can result from any structural or functional cardiac disorder

More information

Chapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure

Chapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure Chapter 10 Congestive Heart Failure Learning Objectives Explain concept of polypharmacy in treatment of congestive heart failure Explain function of diuretics Learning Objectives Discuss drugs used for

More information

Heart Failure CTSHP Fall Seminar

Heart Failure CTSHP Fall Seminar Heart Failure CTSHP Fall Seminar Laurajo Ryan, PharmD, MSc, BCPS, CDE Pharmacist Learning Objectives Outline the pathophysiology of heart failure List triggers for decompensated heart failure Describe

More information

Nora Goldschlager, M.D. SFGH Division of Cardiology UCSF

Nora Goldschlager, M.D. SFGH Division of Cardiology UCSF CLASSIFICATION OF HEART FAILURE Nora Goldschlager, M.D. SFGH Division of Cardiology UCSF DISCLOSURES: NONE CLASSIFICATION C OF HEART FAILURE NYHA I IV New paradigm Stage A: Pts at high risk of developing

More information

The Failing Heart in Primary Care

The Failing Heart in Primary Care The Failing Heart in Primary Care Hamid Ikram How fares the Heart Failure Epidemic? 4357 patients, 57% women, mean age 74 years HFSA 2010 Practice Guideline (3.1) Heart Failure Prevention A careful and

More information

Innovation therapy in Heart Failure

Innovation therapy in Heart Failure Innovation therapy in Heart Failure P. Laothavorn September 2015 Topics of discussion Basic Knowledge about heart failure Standard therapy New emerging therapy References: standard Therapy in Heart Failure

More information

Objectives. Let s start at the beginning 10/28/2014. What is Heart Failure? Understanding Heart Failure with Preserved LV Systolic Function

Objectives. Let s start at the beginning 10/28/2014. What is Heart Failure? Understanding Heart Failure with Preserved LV Systolic Function Understanding Heart Failure with Preserved LV Systolic Function Eric Ernst, MD Medical Director C.O.R.E. Clinic Objectives Clarify the terminology surrounding right heart failure and diastolic heart failure

More information

Definition: A state in which the heart cannot provide sufficient cardiac output to satisfy the metabolic needs of the body

Definition: A state in which the heart cannot provide sufficient cardiac output to satisfy the metabolic needs of the body Definition: A state in which the heart cannot provide sufficient cardiac output to satisfy the metabolic needs of the body HF is a complex clinical syndrome that can result from any structural or functional

More information

2

2 1 2 Although the term "cardiomyopathy" could theoretically apply to almost any disease affecting the heart, it is usually reserved for "severe myocardial disease leading to heart failure".cardiomyopathy

More information

Heart Failure with Johnny Crash: LEFT VENTRICULAR EJECTION FRACTION (LVEF) SYMPTOMATOLOGY: Assess VENTRICULAR DYSFUNCTION HEART FAILURE:

Heart Failure with Johnny Crash: LEFT VENTRICULAR EJECTION FRACTION (LVEF) SYMPTOMATOLOGY: Assess VENTRICULAR DYSFUNCTION HEART FAILURE: Heart Failure with Johnny Crash: Joan E. King, PhD, ACNP-BC, ANP-BC Melissa Smith, DNP, ANP-BC Vanderbilt University School of Nursing HEART FAILURE: Heart Failure (HF): a complex clinical syndrome resulting

More information

Susan P. D Anna MSN, APRN BC February 14, 2019

Susan P. D Anna MSN, APRN BC February 14, 2019 Is there Equal Opportunity in Heart Failure?? Susan P. D Anna MSN, APRN BC February 14, 2019 Disclosures: I have no financial disclosures. I am not an expert on this topic, but see a lot of women with

More information

Heart failure. Failure? blood supply insufficient for body needs. CHF = congestive heart failure. increased blood volume, interstitial fluid

Heart failure. Failure? blood supply insufficient for body needs. CHF = congestive heart failure. increased blood volume, interstitial fluid Failure? blood supply insufficient for body needs CHF = congestive heart failure increased blood volume, interstitial fluid Underlying causes/risk factors Ischemic heart disease (CAD) 70% hypertension

More information

Cardiovascular Disorders. Heart Disorders. Diagnostic Tests for CV Function. Bio 375. Pathophysiology

Cardiovascular Disorders. Heart Disorders. Diagnostic Tests for CV Function. Bio 375. Pathophysiology Cardiovascular Disorders Bio 375 Pathophysiology Heart Disorders Heart disease is ranked as a major cause of death in the U.S. Common heart diseases include: Congenital heart defects Hypertensive heart

More information

Heart Failure in Women: Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre

Heart Failure in Women: Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre Heart Failure in Women: More than EF? Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre Overview Review pathophysiology as it relates to diagnosis and management Rational approach to workup:

More information

Cardiomyopathy. Jeff Grubbe MD FACP, Chief Medical Director, Allstate Life & Retirement

Cardiomyopathy. Jeff Grubbe MD FACP, Chief Medical Director, Allstate Life & Retirement Cardiomyopathy Jeff Grubbe MD FACP, Chief Medical Director, Allstate Life & Retirement Nebraska Home Office Life Underwriters Association March 20, 2018 1 Cardiomyopathy A myocardial disorder in which

More information

Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό

Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό Diastolic HF DD: Diastolic Dysfunction DHF: Diastolic HF HFpEF: HF with preserved EF DD Pathophysiologic condition: impaired relaxation, LV compliance, LV filling

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

Cardiac Drugs: Chapter 9 Worksheet Cardiac Agents. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate.

Cardiac Drugs: Chapter 9 Worksheet Cardiac Agents. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate. Complete the following. 1. drugs affect the rate of the heart and can either increase its rate or decrease its rate. 2. drugs affect the force of contraction and can be either positive or negative. 3.

More information

SymBioSys Exercise 2 Cardiac Function Revised and reformatted by C. S. Tritt, Ph.D. Last updated March 20, 2006

SymBioSys Exercise 2 Cardiac Function Revised and reformatted by C. S. Tritt, Ph.D. Last updated March 20, 2006 SymBioSys Exercise 2 Cardiac Function Revised and reformatted by C. S. Tritt, Ph.D. Last updated March 20, 2006 The goal of this exercise to explore the behavior of the heart as a mechanical pump. For

More information

(D) (E) (F) 6. The extrasystolic beat would produce (A) increased pulse pressure because contractility. is increased. increased

(D) (E) (F) 6. The extrasystolic beat would produce (A) increased pulse pressure because contractility. is increased. increased Review Test 1. A 53-year-old woman is found, by arteriography, to have 5% narrowing of her left renal artery. What is the expected change in blood flow through the stenotic artery? Decrease to 1 2 Decrease

More information

Examen MMD Which of the following causes increased inotropy and chronotropy? A Ca gluconate B Glucagon C Atropine D Digoxin E Phenylephrine

Examen MMD Which of the following causes increased inotropy and chronotropy? A Ca gluconate B Glucagon C Atropine D Digoxin E Phenylephrine 1-Which of the following causes an increase in HR in a denervated heart? A Pancuronium B Atropine C Propranolol D Norepinephrine E Neostigmine 2-Which of the following causes increased inotropy and chronotropy?

More information

Skin supplied by T1-4 (medial upper arm and neck) T5-9- epigastrium Visceral afferents from skin and heart are the same dorsal root ganglio

Skin supplied by T1-4 (medial upper arm and neck) T5-9- epigastrium Visceral afferents from skin and heart are the same dorsal root ganglio Cardio 2 ECG... 3 Cardiac Remodelling... 11 Valvular Diseases... 13 Hypertension... 18 Aortic Coarctation... 24 Erythropoiesis... 27 Haemostasis... 30 Anaemia... 36 Atherosclerosis... 44 Angina... 48 Myocardial

More information

Management of acute decompensated heart failure and cardiogenic shock. Arintaya Phrommintikul Department of Medicine CMU

Management of acute decompensated heart failure and cardiogenic shock. Arintaya Phrommintikul Department of Medicine CMU Management of acute decompensated heart failure and cardiogenic shock Arintaya Phrommintikul Department of Medicine CMU Acute heart failure: spectrum Case 64 y/o M with Hx of non-ischemic DCM (LVEF=25-30%)

More information

IP: Regulation of Cardiac Output

IP: Regulation of Cardiac Output ANP 1105D Winter 2013 Assignment 9: The Heart, part 2: Chap... Assignment 9: The Heart, part 2: Chapter 18 Signed in as Alex Sokolowski Help Close Resources Due: 11:59pm on Monday, March 25, 2013 Note:

More information

SPECIAL PATHOPHYSIOLOGY CARDIO-VASCULAR SYSTEM

SPECIAL PATHOPHYSIOLOGY CARDIO-VASCULAR SYSTEM 1. Myocardia lischemia is mainly a result of: 1.Coronary hypoxemia. 2. Coronary artery disease (CAD). 3. Acute coronaritis. 4. Coronary anemia. 5. Heart remodelling. SPECIAL PATHOPHYSIOLOGY CARDIO-VASCULAR

More information

Disclosure Statement. Heart Failure: Refreshers and Updates. Objectives. CHF: Chronic Heart Failure. Definitions. Definitions 2/19/2018

Disclosure Statement. Heart Failure: Refreshers and Updates. Objectives. CHF: Chronic Heart Failure. Definitions. Definitions 2/19/2018 Disclosure Statement Heart Failure: Refreshers and Updates Tracy K. Pettinger, PharmD Clinical Associate Professor College of Pharmacy The planners and presenter of this presentation have disclosed no

More information

Review of Cardiac Imaging Modalities in the Renal Patient. George Youssef

Review of Cardiac Imaging Modalities in the Renal Patient. George Youssef Review of Cardiac Imaging Modalities in the Renal Patient George Youssef ECHO Left ventricular hypertrophy (LVH) assessment Diastolic dysfunction Stress ECHO Cardiac CT angiography Echocardiography - positives

More information

CHF is a clinical syndrome in which heart failure is accompanied by symptoms and signs of pulmonary and/or peripheral congestion

CHF is a clinical syndrome in which heart failure is accompanied by symptoms and signs of pulmonary and/or peripheral congestion Congestive Heart Failure Lokesh Tejwani, MD Heart Failure A patho-physiological state in which abnormality of cardiac function is responsible for failure of the heart to pump blood at a rate commensurate

More information

Incidence. 4.8 million in the United States. 400,000 new cases/year. 20 million patients with asymptomatic LV dysfunction

Incidence. 4.8 million in the United States. 400,000 new cases/year. 20 million patients with asymptomatic LV dysfunction Heart Failure Diagnosis According to the Working Group in Heart Failure, CHF is a syndrome where the diagnosis has the following essential components: A combination of: Symptoms, typically breathlessness

More information

Cardiology. the Sounds: #7 HCM. LV Outflow Obstruction: Aortic Stenosis. (Coming Soon - HCM)

Cardiology. the Sounds: #7 HCM. LV Outflow Obstruction: Aortic Stenosis. (Coming Soon - HCM) A Cardiology HCM LV Outflow Obstruction: Aortic Stenosis (Coming Soon - HCM) the Sounds: #7 Howard J. Sachs, MD www.12daysinmarch.com E-mail: Howard@12daysinmarch.com Aortic Valve Disorders Stenosis Regurgitation

More information

Why guess when you could know? Gold Standard. Cardiac catheterization (Angiogram) Invasive Risks: Infection, hematoma, death

Why guess when you could know? Gold Standard. Cardiac catheterization (Angiogram) Invasive Risks: Infection, hematoma, death Why guess when you could know? Gold Standard Cardiac catheterization (Angiogram) Invasive Risks: Infection, hematoma, death PCI decisions Number of vessels involved Surgeon experience level The anatomic

More information

Heart Failure. Jay Shavadia

Heart Failure. Jay Shavadia Heart Failure Jay Shavadia Definition Clinical syndrome characterized by: Symptoms: breathlessness at rest or on exercise, fatigue, tiredness or ankle swelling AND Signs: tachycardia, tachypnea, pulmonary

More information

State-of-the-Art Management of Chronic Systolic Heart Failure

State-of-the-Art Management of Chronic Systolic Heart Failure State-of-the-Art Management of Chronic Systolic Heart Failure Michael McCulloch, MD 17 th Annual Cardiovascular Update Intermountain Medical Center December 16, 2017 Disclosures: I have no financial disclosures

More information

FUNDAMENTALS OF HEMODYNAMICS, VASOACTIVE DRUGS AND IABP IN THE FAILING HEART

FUNDAMENTALS OF HEMODYNAMICS, VASOACTIVE DRUGS AND IABP IN THE FAILING HEART FUNDAMENTALS OF HEMODYNAMICS, VASOACTIVE DRUGS AND IABP IN THE FAILING HEART CINDY BITHER, MSN, ANP, ANP, AACC, CHFN CHIEF NP, ADV HF PROGRAM MEDSTAR WASHINGTON HOSPITAL CENTER CONFLICTS OF INTEREST NONE

More information

Heart Failure Clinician Guide JANUARY 2016

Heart Failure Clinician Guide JANUARY 2016 Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2016 Introduction This evidence-based guideline summary is based on the 2016 National Heart Failure Guideline.

More information

LCZ696 A First-in-Class Angiotensin Receptor Neprilysin Inhibitor

LCZ696 A First-in-Class Angiotensin Receptor Neprilysin Inhibitor The Angiotensin Receptor Neprilysin Inhibitor LCZ696 in Heart Failure with Preserved Ejection Fraction The Prospective comparison of ARNI with ARB on Management Of heart failure with preserved ejection

More information

Etiology, Classification & Management. Sheba Medical Center Cardiology Department Matthew Wright St. George s University of London

Etiology, Classification & Management. Sheba Medical Center Cardiology Department Matthew Wright St. George s University of London Etiology, Classification & Management Sheba Medical Center Cardiology Department Matthew Wright St. George s University of London Introduction World Health Organization (1995): Diseases of myocardium (heart

More information

In Vivo Animal Models of Heart Disease. Why Animal Models of Disease? Timothy A Hacker, PhD Department of Medicine University of Wisconsin-Madison

In Vivo Animal Models of Heart Disease. Why Animal Models of Disease? Timothy A Hacker, PhD Department of Medicine University of Wisconsin-Madison In Vivo Animal Models of Heart Disease Timothy A Hacker, PhD Department of Medicine University of Wisconsin-Madison Why Animal Models of Disease? Heart Failure (HF) Leading cause of morbidity and mortality

More information

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors

Lecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors Lecture 8 Cardiovascular Health 1 Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors 1 Human Health: What s Killing Us? Health in America Health is the U.S Average life

More information

Drugs Used in Heart Failure. Assistant Prof. Dr. Najlaa Saadi PhD pharmacology Faculty of Pharmacy University of Philadelphia

Drugs Used in Heart Failure. Assistant Prof. Dr. Najlaa Saadi PhD pharmacology Faculty of Pharmacy University of Philadelphia Drugs Used in Heart Failure Assistant Prof. Dr. Najlaa Saadi PhD pharmacology Faculty of Pharmacy University of Philadelphia Heart Failure Heart failure (HF), occurs when cardiac output is inadequate to

More information

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition Table of Contents Volume 1 Chapter 1: Cardiovascular Anatomy and Physiology Basic Cardiac

More information

DOWNLOAD PDF ABC OF HEART FAILURE

DOWNLOAD PDF ABC OF HEART FAILURE Chapter 1 : The ABCs of managing systolic heart failure: Past, present, and future Heart failure is a multisystem disorder which is characterised by abnormalities of cardiac, skeletal muscle, and renal

More information